Drugs / BIIB063
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02555085 | Sep 2015 → Jun 2016 | — | Biogen | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIIB063 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02555085 ↗ |
| Route | Intravenous | “single ascending intravenous (IV) doses” NCT02555085 ↗ |